Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of pharmaceutical composition and its application

A composition and drug technology, applied in the direction of drug combination, non-active ingredients of polymer compounds, anti-tumor drugs, etc., can solve the problems of different molecular properties, achieve significant drug efficacy, and inhibit tumor growth

Active Publication Date: 2022-05-06
SIRNAOMICS BIOPHARMACEUTICALS (SUZHOU) CO LTD
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the molecular properties of siRNA and miRNA are different, so whether HKP can be used to introduce miRNA in vivo still needs to be studied

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of pharmaceutical composition and its application
  • A kind of pharmaceutical composition and its application
  • A kind of pharmaceutical composition and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0059] Example 1. Agarose gel electrophoresis experiment analysis of the appropriate nitrogen and phosphorus mass ratio (N / P) of HKP and miR-150

[0060] Agarose gel electrophoresis is an electrophoresis method using agarose as a supporting medium, which has the dual functions of "molecular sieve" and "electrophoresis". The separation of charged particles depends not only on the nature and quantity of the net charge, but also on the size of the molecule. It is a common method for nucleic acid separation and detection, and 1% agarose is commonly used as an electrophoresis support. In this experiment, 1% agarose gel was used to observe the loading capacity of HKP on micro RNA.

[0061] HKP uses two outsourcing companies from Mixson and API, which synthesize HKP according to the technology owned by the patentee, and conduct the pre-screening test of nitrogen and phosphorus mass ratio with Mimics respectively, setting the following five ratios: 1:1, 2:1, 4 :1, 6:1, 8:1.

[0062]...

Embodiment 2

[0063] Example 2. Experimental Analysis of Particle Size and Potential Data Measurement Appropriate Nitrogen-Phosphorus Mass Ratio (N / P) of HKP and miR-150

[0064] Dynamic Light Scattering (DLS) measurement of particle size has the advantages of accuracy, speed, and good repeatability, and has become a relatively routine characterization method in nanotechnology. The laser particle size analyzer using the principle of dynamic light scattering can directly measure the particle size distribution of the nanoparticle suspension.

[0065] Zeta potential, also known as zeta potential or zeta potential (ζ-potential or ζ-potential), refers to the potential of the shear plane (ShearPlane), and is an important indicator to characterize the stability of nano-solution dispersion system. It is the potential difference between the continuous phase and the fluid stable layer attached to the dispersed particles, which can be directly measured by electrokinetic phenomena. A zeta potentiomete...

Embodiment 3

[0071] Example 3. Encapsulation Efficiency Determination Experimental Analysis of the Appropriate Nitrogen-Phosphorus Mass Ratio (N / P) of miR-150 and HKP

[0072] RiboGreen RNA Quantitation Reagent is an ultrasensitive nucleic acid fluorescent dye that allows simple and rapid quantification of RNA in solution.

[0073] When RiboGreen fluorescent dye is in a solution state, it has almost no fluorescence activity; when RiboGreen is combined with RNA, its fluorescence activity will increase by 1000 times. The fluorescence excitation wavelength of RiboGreen-RNA complex is about 500nm, and the emission wavelength is about 525nm.

[0074] When the RibGreen fluorescent dye is added to the solution, the free miRNA will bind to it, forming a RiboGreen-RNA complex with fluorescent activity. However, the miRNA encapsulated by HKP will not bind to the RibGreen fluorescent dye and will not produce fluorescent activity. Therefore, by drawing the standard curve with the fluorescence degree...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a pharmaceutical composition and its application. The pharmaceutical composition is a novel pharmaceutical product composed of one or more micronucleic acid inhibitors and polypeptide nanocarriers, which can be used to prepare and treat cancer drugs including colon cancer or rectal cancer. . This novel pharmaceutical product includes micro RNA molecule micro RNA with or without chemical modification, and a carrier suitable for in vivo introduction, and the carrier is a histidine-lysine branched polypeptide or a modified product thereof. For example, a micronucleic acid polypeptide nano-preparation can be formed after mixing the micronucleic acid and the carrier. The invention provides the preparation and its application method as a candidate new drug for treating colorectal cancer, and relates to a novel anti-tumor mechanism. Through the examples of pharmacodynamic studies at the cell level and animal level, it has been proved that this new innovative drug can induce the programmed death of colorectal cancer cells, thereby inhibiting the tumor growth of colorectal cancer, and has significant efficacy.

Description

technical field [0001] The invention belongs to the technical field of new medicines, and in particular relates to a pharmaceutical composition and its application. Background technique [0002] Colorectal cancer is one of the common malignant tumors. It ranks second in the incidence of malignant tumors in developed countries such as Europe and the United States, and ranks third in the world. With the continuous improvement of the living standards of Chinese residents and the increasing Westernization of eating habits, the incidence of colorectal cancer has also increased year by year, ranking 3rd to 5th, especially in large cities. At present, the treatment of colorectal cancer only uses drugs that have a therapeutic effect on tumors, and the lack of targeted therapy drugs for colorectal cancer makes the treatment of colorectal cancer poor. This situation needs to be improved urgently. [0003] miR-150 inhibits the proliferation of colorectal cancer cells [0004] Using m...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K48/00A61K31/7105A61K47/42A61K45/06A61K39/395A61P35/00
CPCA61K47/42A61K48/00A61P35/00A61K31/7105C12Q2600/178A61K47/10G01N33/57419
Inventor 路阳秦环龙刘梦晗陆阳
Owner SIRNAOMICS BIOPHARMACEUTICALS (SUZHOU) CO LTD